NIH VideoCast - Mechanistic Discovery in Murine Cancer Models: From Basic Discovery to Clinical Translation (NIH-Only)

Skip Navigation

Mechanistic Discovery in Murine Cancer Models: From Basic Discovery to Clinical Translation (NIH-Only)HHS Only

Loading... Loading video...

Air date:	Tuesday, May 4, 2010, 8:00:00 AM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 92 * This only includes stats from October 2011 and forward.
Category:	NCI CCR Grand Rounds (HHS Only)
Runtime:	01:08:55
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	Dr. Van Dyke received her Ph.D. in Medical Sciences from the University of Florida in 1981. As a Post-doctoral Fellow in Dr. Arnold Levine's lab in the early 1980s, she characterized one of the first transgenic cancer models. In 1993, Dr. Van Dyke joined the University of North Carolina (UNC), where she is currently a Sarah Graham Kenan Distinguished Professor of Genetics with a joint appointment in Biochemistry and Biophysics. UNC affiliations include the Lineberger Comprehensive Cancer Center, Neuroscience Center, Program in Molecular Biology and Biotechnology, Carolina Center for Genome Sciences, and Carolina Center for Cancer Nanotechnology Excellence.In 1998, Dr. Van Dyke became the Facility Director of the UNC Animal Models Core Facility and in 1999, she established the Carolina Mutant Mouse Regional Resource Center (MMRRC), one of four in the country. In the late 1990s, Dr. Van Dyke served as co-chair of an advisory committee to the Director of NCI on the use of mouse models to advance cancer research. This work led to the establishment of the Mouse Models of Human Cancers Consortium (MMHCC). Dr. Van Dyke continued to serve as co-chair of the MMHCC for more than 2 years with its inception and provided significant leadership in initiatives undertaken by the steering committee, including the establishment of a national repository for GEM mice, and internationally accessible database for mouse models of cancer and associated strains, and a web site for information including summaries of human cancers and mouse cancer models. Dr. Van Dyke continues to serve as a MMHCC PI, leading a multi-institutional collaboration on astrocytic cancers. NCI’s Center for Cancer Research (CCR) Grand Rounds is a weekly lecture series addressing current research in clinical and molecular oncology. Speakers are leading national and international researchers and clinicians proposed by members of the CCR Grand Rounds Planning Committee and others within the CCR community and approved by the CCR Office of the Director. Lectures occur every Tuesday from 8:00 to 9:00 a.m. in Lipsett Amphitheater in the Clinical Center building on the NIH campus September through July with exceptions around holidays and major cancer meetings. The lecture schedule is posted on various calendars of events, including at the following link: http://bethesdatrials.cancer.gov/health-care-professionals/grand-rounds.aspx.

NLM Title:	Mechanistic discovery in murine cancer models : from basic discovery to clinical translation / Terry A. Van Dyke.
Author:	Van Dyke, Terry A. Center for Cancer Research (National Cancer Institute (U.S.))
Publisher:
Abstract:	(CIT): Dr. Van Dyke received her Ph.D. in Medical Sciences from the University of Florida in 1981. As a Post-doctoral Fellow in Dr. Arnold Levine's lab in the early 1980s, she characterized one of the first transgenic cancer models. In 1993, Dr. Van Dyke joined the University of North Carolina (UNC), where she is currently a Sarah Graham Kenan Distinguished Professor of Genetics with a joint appointment in Biochemistry and Biophysics. UNC affiliations include the Lineberger Comprehensive Cancer Center, Neuroscience Center, Program in Molecular Biology and Biotechnology, Carolina Center for Genome Sciences, and Carolina Center for Cancer Nanotechnology Excellence.In 1998, Dr. Van Dyke became the Facility Director of the UNC Animal Models Core Facility and in 1999, she established the Carolina Mutant Mouse Regional Resource Center (MMRRC), one of four in the country. In the late 1990s, Dr. Van Dyke served as co-chair of an advisory committee to the Director of NCI on the use of mouse models to advance cancer research. This work led to the establishment of the Mouse Models of Human Cancers Consortium (MMHCC). Dr. Van Dyke continued to serve as co-chair of the MMHCC for more than 2 years with its inception and provided significant leadership in initiatives undertaken by the steering committee, including the establishment of a national repository for GEM mice, and internationally accessible database for mouse models of cancer and associated strains, and a web site for information including summaries of human cancers and mouse cancer models. Dr. Van Dyke continues to serve as a MMHCC PI, leading a multi-institutional collaboration on astrocytic cancers. NCI"s Center for Cancer Research (CCR) Grand Rounds is a weekly lecture series addressing current research in clinical and molecular oncology. Speakers are leading national and international researchers and clinicians proposed by members of the CCR Grand Rounds Planning Committee and others within the CCR community and approved by the CCR Office of the Director. Lectures occur every Tuesday from 8:00 to 9:00 a.m. in Lipsett Amphitheater in the Clinical Center building on the NIH campus September through July with exceptions around holidays and major cancer meetings. The lecture schedule is posted on various calendars of events, including at the following link: http://bethesdatrials.cancer.gov/health-care-professionals/grand-rounds.aspx.
Subjects:	Biomedical Research Models, Animal Murinae Neoplasms
Publication Types:	Lecture Webcast
NLM Classification:	QZ 206
NLM ID:	101532583
CIT Live ID:	9278
Permanent link:	https://videocast.nih.gov/watch=9278

Related Videos...